Stock Research for SNY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SNY Stock Chart & Research Data

The SNY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SNY Due diligence Resources & Stock Charts

The SNY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SNY Detailed Price Forecast - CNN Money CNN View SNY Detailed Summary - Google Finance
Yahoo View SNY Detailed Summary - Yahoo! Finance Zacks View SNY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SNY Trends & Analysis - Trade-Ideas Barrons View SNY Major Holders - Barrons
NASDAQ View SNY Call Transcripts - NASDAQ Seeking View SNY Breaking News & Analysis - Seeking Alpha
Spotlight View SNY Annual Report - CompanySpotlight.com OTC Report View SNY OTC Short Report - OTCShortReport.com
TradeKing View SNY Fundamentals - TradeKing Charts View SNY SEC Filings - Bar Chart
WSJ View Historical Prices for SNY - The WSJ Morningstar View Performance/Total Return for SNY - Morningstar
MarketWatch View the Analyst Estimates for SNY - MarketWatch CNBC View the Earnings History for SNY - CNBC
StockMarketWatch View the SNY Earnings - StockMarketWatch MacroAxis View SNY Buy or Sell Recommendations - MacroAxis
Bullish View the SNY Bullish Patterns - American Bulls Short Pains View SNY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SNY Stock Mentions - StockTwits PennyStocks View SNY Stock Mentions - PennyStockTweets
Twitter View SNY Stock Mentions - Twitter Invest Hub View SNY Investment Forum News - Investor Hub
Yahoo View SNY Stock Mentions - Yahoo! Message Board Seeking Alpha View SNY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SNY - SECform4.com Insider Cow View Insider Transactions for SNY - Insider Cow
CNBC View SNY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SNY - OTC Markets
Yahoo View Insider Transactions for SNY - Yahoo! Finance NASDAQ View Institutional Holdings for SNY - NASDAQ


Stock Charts

FinViz View SNY Stock Insight & Charts - FinViz.com StockCharts View SNY Investment Charts - StockCharts.com
BarChart View SNY Stock Overview & Charts - BarChart Trading View View SNY User Generated Charts - Trading View




Latest Financial News for SNY


Mylan says Sanofi loses Lantus insulin patent claims
Posted on Thursday December 13, 2018

Sanofi is heavily reliant on Lantus, its leading product with sales of 4.62 billion euros ($5.26 billion) in 2017, and Mylan's own insulin drug would be its second competitor after Eli Lilly launched its version in late 2016. Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and paediatric patients with type 1 diabetes to control high blood sugar. Sanofi, which settled a similar case with Lilly in 2016, allowing it to launch Basaglar, sued Mylan in October 2017.


Mylan says patent office cancels Sanofi's Lantus patents
Posted on Thursday December 13, 2018

Mylan N.V. said on Thursday the U.S. Patent and Trademark Office invalidated French drug company Sanofi's formulation patents on its blockbuster insulin drug Lantus, ruling in favor of the U.S. drugmaker. ...


Warren Buffett's 10 Big Stock Losers
Posted on Tuesday December 11, 2018


Boehringer Ingelheim plans to cut about 300 jobs in France
Posted on Monday December 10, 2018

German drugmaker Boehringer Ingelheim told unions on Monday that it plans to cut some 300 jobs in France as part of efforts to reorganise activities around its hub in Lyon following an asset swap with Sanofi (SASY.PA) in 2017. Unlisted Boehringer agreed in January last year to trade its consumer health division in exchange for France's Sanofi animal health arm Merial in a $20 billion transaction. Boehringer Ingelheim's chairman for France, Jean Scheftsik de Szolnok, told Reuters the company was planning to cut up to 327 jobs out of a 2,800 workforce in France.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.